Table 1.
Description of the AB officer's role
| Subgroup |
Clarithromycin |
Placebo |
|---|---|---|
| Sex | ||
| Female | 148/658 (22.4) | 122/681 (17.9) |
| Male | 349/1,514 (23.0) | 304/1,519 (20.1) |
| Age | ||
| Below 60 years | 70/640 (10.9) | 45/663 (6.7) |
| At or above 60 years | 427/1,532 (27.8) | 381/1,537 (24.7) |
| Prior myocardial infarction | ||
| No | 124/702 (17.6) | 123/706 (17.4) |
| Yes | 373/1,470 (25.3) | 303/1,494 (20.2) |
| Diabetes mellitus1 | ||
| No | 405/1,831 (22.1) | 341/1,863 (18.3) |
| Yes | 92/341 (26.9) | 85/337 (25.2) |
| Smoking status | ||
| Never | 65/372 (17.5) | 66/435 (15.2) |
| Previous | 218/981 (22.2) | 192/1,012 (18.9) |
| Current | 214/819 (26.1) | 168/753 (22.3) |
1
One surviving placebo-treated patient lacked information on diabetes status and is included in the no diabetes mellitus group.